Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

669

Full text

563

Free full text

296

Publication Types

Journal Article

679

Review

286

Research Support, Non-U.S. Gov't

215

Comparative Study

132

Randomized Controlled Trial

112

Multicenter Study

111

Observational Study

Systematic Review

Meta-Analysis

Network Meta-Analysis

Clinical Trial

Clinical Trial, Phase III

Case Reports

Research Support, N.I.H., Extramural

Clinical Trial, Phase II

Letter

Clinical Trial Protocol

Equivalence Trial

Controlled Clinical Trial

Comment

Consensus Development Conference

Practice Guideline

Editorial

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase IV

Validation Study

Evaluation Study

Clinical Trial, Phase I

Video-Audio Media

Scoping Review

Pragmatic Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Rivaroxaban""[mesh_terms]

696 Results

Searching titles within these results

Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions.

Tomas Kvasnicka, Ivana Malikova, Zuzana Zenahlikova, Karolína Kettnerova, Radka Brzezkova, Tomas Zima, Jan Ulrych, Jan Briza, Ivan Netuka, Jan Kvasnicka

Current drug metabolism 2018;18(7):636-642

Full Text

Abstract

Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis.

Nazariy Koval, Mariana Alves, Rui Plácido, Ana G Almeida, João Eurico Fonseca, Joaquim J Ferreira, Fausto J Pinto, Daniel Caldeira

RMD open 2021;7(2):e001678

Free Full Text

Abstract

Controversies in Stoppage of Antiplatelet and Anticoagulant Medications Prior to Oral Surgery.

Michael H Chan, Feiyi Sun, Jonathan Malakan

Dental clinics of North America 2023;68(1):21-45

Full Text

Abstract

Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: A systematic review and meta-analysis.

Ruihao Li, Manqiu Yuan, Junning Cheng, Shixiong Yu, Wei Wei, Wenlong Fu, Paolo Prandoni, Yikuan Chen

Thrombosis research 2021;196():340-348

Full Text

Abstract

Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr.

Anthonie W A Lensing, Ákos F Pap, Kirstin Thelen, Dagmar Kubitza, Stefan Willmann, Joseph S Palumbo, Leonardo R Brandão, Hélène L Hooimeijer, Gili Kenet, Heleen van Ommen, Madhurima Majumder, Martin H Prins, Paul Monagle, Christoph Male

Blood advances 2022;6(22):5821-5828

Free Full Text

Abstract

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, Elizabeth Chalmers, Krisztián Kállay, Kerry Hege, Paolo Simioni, Tina Biss, Fanny Bajolle, Damien Bonnet, Sebastian Grunt, Riten Kumar, Olga Lvova, Rukhmi Bhat, An Van Damme, Joseph Palumbo, Amparo Santamaria, Paola Saracco, Jeanette Payne, Susan Baird, Kamar Godder, Veerle Labarque, Christoph Male, Ida Martinelli, Michelle Morales Soto, Jayashree Motwani, Sanjay Shah, Helene L Hooimeijer, Martin H Prins, Dagmar Kubitza, William T Smith, Scott D Berkowitz, Akos F Pap, Madhurima Majumder, Paul Monagle, Jonathan M Coutinho

Blood advances 2021;4(24):6250-6258

Free Full Text

Abstract

Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice: Focus on Rivaroxaban in Stroke Prevention in Patients With Atrial Fibrillation.

Marcelo Sanmartín-Fernández, Domingo Marzal-Martín

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2018;23(7):711-724

Free Full Text

Abstract

Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies.

Zhi-Yan Liu, Han-Xu Zhang, Ling-Yue Ma, Guang-Yan Mu, Qiu-Fen Xie, Shuang Zhou, Zi-Ning Wang, Zhe Wang, Kun Hu, Qian Xiang, Yi-Min Cui

BMC cardiovascular disorders 2022;22(1):105

Free Full Text

Abstract

An Update on Betrixaban, The Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis.

Ali Akbar Moghadamnia, Yasaman Daryabari, Fnu Amreek, Pouya Tayebi

Journal of cardiovascular pharmacology 2024;83(2):134-143

Full Text

Abstract

Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis.

Christos Karathanos, Petroula Nana, Konstantinos Spanos, George Kouvelos, Alexandros Brotis, Miltiadis Matsagas, Athanasios Giannoukas

Journal of vascular surgery. Venous and lymphatic disorders 2022;9(6):1568-1576.e1

Free Full Text

Abstract

Pharmacokinetics and pharmacodynamics of direct oral anticoagulants.

B Hindley, G Y H Lip, A P McCloskey, P E Penson

Expert opinion on drug metabolism & toxicology 2024;19(12):911-923

Free Full Text

Abstract

Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis.

Rupert Bauersachs, Olivia Wu, Neil Hawkins, Kevin Bowrin, Piotr Wojciechowski, Emilie Clay, Maria Huelsebeck

Cardiovascular therapeutics 2021;2021():8561350

Free Full Text

Abstract

The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

Paolo Prandoni, Sally Temraz, Sofia Barbar, Raffaele Pesavento, Alì Taher

Internal and emergency medicine 2016;9(6):617-22

Full Text

Abstract

Latest advances in preventing thromboembolic disease in the ambulatory oncology patient.

Anthony Maraveyas

Thrombosis research 2021;191 Suppl 1():S91-S98

Full Text

Abstract

Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.

Jeffrey A Kline, David H Adler, Naomi Alanis, Joseph R Bledsoe, Daniel M Courtney, James P d'Etienne, Deborah B Diercks, John S Garrett, Alan E Jones, David C Mackenzie, Troy Madsen, Andrew J Matuskowitz, Bryn E Mumma, Kristen E Nordenholz, Justine Pagenhardt, Michael S Runyon, William B Stubblefield, Christopher B Willoughby

Circulation. Cardiovascular quality and outcomes 2021;14(7):e007600

Free Full Text

Abstract

Results: 1 – 15 / 696

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Rivaroxaban""[mesh_terms]

Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions.

Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis.

Controversies in Stoppage of Antiplatelet and Anticoagulant Medications Prior to Oral Surgery.

Risk of post-thrombotic syndrome after deep vein thrombosis treated with rivaroxaban versus vitamin-K antagonists: A systematic review and meta-analysis.

Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr.

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice: Focus on Rivaroxaban in Stroke Prevention in Patients With Atrial Fibrillation.

Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies.

An Update on Betrixaban, The Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis.

Efficacy of rivaroxaban in prevention of post-thrombotic syndrome: A systematic review and meta-analysis.

Pharmacokinetics and pharmacodynamics of direct oral anticoagulants.

Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis.

The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

Latest advances in preventing thromboembolic disease in the ambulatory oncology patient.

Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.

Results for
""Rivaroxaban""[mesh_terms]